Sorrento finds a coronavirus antibody that blocks viral infection 100% in preclinical lab experiments

Therapeutics company Sorrento has made what it believes could be a breakthrough in potential treatment of SARS-CoV-2, the virus that leads to COVID-19. The company released details of its preclinical research on Friday, announcing that it has found an antibody that provides “100% inhibition of SARS-CoV-2 virus infection of healthy cells after four days incubation.” The results are from a preclinical study that still has to undergo peer review.
Read more: https://techcrunch.com/2020/05/15/sorrento-finds-a-coronavirus-antibody-that-blocks-viral-infection-100-in-preclinical-lab-experiments/?source=Snapzu